WEST
DEAD

Serial Number

86957724

Owner

WEST PHARMACEUTICAL SERVICES, INC.

Attorney

Rex A. Donnelly

Filing Date

Mar 30, 2016

Add to watchlist:

No watchlists yet
View on USPTO

WEST Trademark

Serial Number: 86957724

WEST is a trademark filed by WEST PHARMACEUTICAL SERVICES, INC. on March 30, 2016. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 38 (Telecommunications), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

WEST PHARMACEUTICAL SERVICES, INC. (112 trademarks)

530 Herman O. West Drive
Exton, PA 19341

Entity Type: 03

Trademark Details

Filing Date

March 30, 2016

Registration Date

Not Registered

Published for Opposition

June 28, 2022

Goods & Services

Computer application software for mobile phones and handheld computers, namely, interactive patient engagement and medication adherence software for users of wearable injector drug delivery systems; Computer software for facilitating communication between a computer or handheld device connected to the internet and an wearable injector drug delivery system; Downloadable mobile applications for communicating with an wearable injector drug delivery system and for displaying health related information

Broadcast communication services, namely, transmitting emails and text messages notifications to designated recipients for others, namely, alerts, reminders and information related to compliance with health programs relating to wearable injector drug delivery systems

Infusion pumps, sold pre-filled, for facilitating subcutaneous delivery of a wide range of liquid pharmaceutical preparations to patients; infusion pumps sold pre-filled with fluids used for the subcutaneous delivery of pharmaceutical preparations to patients; infusion pumps for delivering liquid pharmaceutical preparations to patients, sold pre-filled with pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; infusion pumps for delivering liquid pharmaceutical preparations to patients, sold pre-filled with insulin

Arranging and conducting incentive reward programs for promoting consumer compliance with prescriptions for medications delivered by wearable injector drug delivery systems; Providing an interactive web site that offers participants rewards for providing information about health and fitness in the nature of their health programs, personal health data and prescription and health conditions, for data collection used in improving healthcare administration and cost management in connection with wearable injector drug delivery systems

Medical information services, namely providing via a website and e-mail and text message notifications, medical information related to compliance with health programs relating to wearable injector drug delivery systems

Computer services, namely, providing an interactive web site featuring technology that allows users to communicate information from wearable injector drug delivery systems; Providing temporary use of non-downloadable computer software for communicating with wearable injector drug delivery systems and for displaying health related information; Providing an interactive web site featuring technology that enables users to enter, access, track, monitor and generate health and medical information and reports relating to wearable injector drug delivery systems; Providing on-line non-downloadable software for authenticating and rewarding compliance with health programs, namely, prescriptions for medications and medical treatment regimens related to wearable injector drug delivery systems; Providing on-line non-downloadable software for users to receive notifications via e-mail, instant message, short message service (SMS), multimedia message service (MMS) or text messages relating to wearable injector drug delivery systems

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Sep 29, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Sep 29, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 15, 2025 EXRA
SOU EXTENSION 5 GRANTED
Jun 2, 2025 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 29, 2025 AITU
SOU TEAS EXTENSION RECEIVED
Feb 13, 2025 EEXT
SOU EXTENSION 5 FILED
Feb 12, 2025 EXT5
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 23, 2024 EXRA
SOU EXTENSION 4 GRANTED
Aug 23, 2024 EX4G
SOU EXTENSION 4 FILED
Aug 23, 2024 EXT4
SOU TEAS EXTENSION RECEIVED
Aug 23, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 24, 2024 EXRA
SOU EXTENSION 3 GRANTED
Feb 23, 2024 EX3G
SOU EXTENSION 3 FILED
Feb 23, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Feb 23, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 24, 2023 EXRA
SOU EXTENSION 2 GRANTED
Aug 22, 2023 EX2G
SOU EXTENSION 2 FILED
Aug 22, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Aug 22, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 23, 2023 EXRA
SOU EXTENSION 1 GRANTED
Feb 21, 2023 EX1G
SOU EXTENSION 1 FILED
Feb 21, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Feb 21, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 23, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 28, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jun 28, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 8, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 18, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 4, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 3, 2022 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
May 3, 2022 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Nov 4, 2021 GNFN
FINAL REFUSAL E-MAILED
Nov 4, 2021 GNFR
FINAL REFUSAL WRITTEN
Nov 4, 2021 CNFR
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
May 4, 2021 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Oct 9, 2020 GNS3
LETTER OF SUSPENSION E-MAILED
Oct 9, 2020 GNSL
SUSPENSION LETTER WRITTEN
Oct 9, 2020 CNSL
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Mar 23, 2020 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Sep 9, 2019 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Feb 25, 2019 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Aug 23, 2018 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Feb 22, 2018 RCSC
ASSIGNED TO LIE
Feb 22, 2018 ALIE
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Aug 7, 2017 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 7, 2017 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 7, 2017 GNSL
SUSPENSION LETTER WRITTEN
Feb 7, 2017 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 18, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 17, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 17, 2017 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 25, 2016 TCCA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 15, 2016 GNRN
NON-FINAL ACTION E-MAILED
Jul 15, 2016 GNRT
NON-FINAL ACTION WRITTEN
Jul 15, 2016 CNRT
ASSIGNED TO EXAMINER
Jul 13, 2016 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Apr 5, 2016 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 2, 2016 NWOS
NEW APPLICATION ENTERED
Apr 2, 2016 NWAP